| Literature DB >> 12431761 |
Vishwanie Budhram-Mahadeo1, Peter Morris, Daniel Ndisang, Shazia Irshad, Guilermina Lozano, Barbara Pedley, David S Latchman.
Abstract
The Brn-3a POU family transcription factor is able to induce the expression of genes encoding anti-apoptotic proteins such as Bcl-2 and Bcl-x and protects neuronal cells from apoptosis. This effect is opposed by the pro-apoptotic p53 protein which completely inhibits the ability of Brn-3a to activate the Bcl-2 and Bcl-x promoters. Here we demonstrate that Brn-3a is able to stimulate p53 expression. Thus, in co-transfection experiments, Brn-3a activates the p53 promoter acting via a region from +22 to +67, located between the most proximal (+1) and the most distal (+105) transcriptional start sites. Similarly, reduction of Brn-3a expression using anti-sense constructs reduces endogenous p53 expression in human neuroblastoma or cervical carcinoma cell lines growing in vitro and as tumours in nude mice whilst increasing Brn-3a levels enhances p53 expression. These results suggest the existence of a negative feedback loop in which elevated Brn-3a expression induces the expression of p53 which, in turn, antagonises the anti-apoptotic activity of Brn-3a. Copyright 2002 Elsevier Science Ireland Ltd.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12431761 DOI: 10.1016/s0304-3940(02)00813-3
Source DB: PubMed Journal: Neurosci Lett ISSN: 0304-3940 Impact factor: 3.046